Rimegepant 75mg Orally Disintegrating Tablets

Product Introduction

Rimegepant 75mg is a calcitonin gene-related peptide receptor antagonist used for acute migraine, with or without aura, in adults. It is also used on a different schedule to prevent episodic migraine. The orally disintegrating tablet dissolves in the mouth.

How to use

With dry hands, peel back the blister foil rather than pushing the tablet through it. Place it on or under the tongue and allow it to dissolve before swallowing. Water is not needed. Take immediately after opening, with or without food.

How it works

Rimegepant blocks the receptor for calcitonin gene-related peptide, or CGRP. This interrupts a signaling pathway involved in migraine pain.

Side effects

Nausea can occur; preventive treatment can also cause abdominal pain or indigestion. Serious allergic reactions may be delayed for days. New or worsening high blood pressure and Raynaud's symptoms have been reported.

Important information

Avoid strong CYP3A4 inhibitors and strong or moderate CYP3A inducers. Other interacting medicines can require a longer interval between doses. Severe liver impairment and end-stage kidney disease need an alternative plan. Report painful, cold or colour-changing fingers or toes.